Neglected Tropical Diseases Diagnosis Market - Forecast(2024 - 2030)
Neglected Tropical Diseases Diagnosis Market Overview
Neglected Tropical Diseases Diagnosis Market size is estimated to reach $7.9 billion by 2026, growing at a CAGR of 4.1% during the forecast period 2021-2026. Neglected tropical diseases (NTDs) are virus, bacterial and parasitic infections that are common in low-income populations and affect poor populations around the world. Owing to the chronic existence of the pathogens, these untreated tropical diseases are also associated with high levels of morbidity.
NTDs are found in settings
with fragile health care systems with weak laboratory infrastructure and specific
point-of-care testing services are needed. Rise in the adoption of
point-of-care testing services at home healthcare, growing demand for rapid
diagnostic tests for the treatment of lymphatic filariasis, and increasing
continuous efforts by the healthcare companies to develop less complicated
disease diagnostic platforms are the factors that are set to drive the growth
of the Neglected Tropical
Diseases Diagnosis Market for the period 2021-2026.
Neglected Tropical Diseases Diagnosis Market Report Coverage
The
report: “Neglected Tropical
Diseases Diagnosis Market Forecast (2021-2026)”, by Industry ARC,
covers an in-depth analysis of the following segments of the Neglected Tropical Diseases Diagnosis
Market.
By
Disease: Dengue, Chikungunya, Rabies, Lymphatic
Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and
Others.
By
Method: Conventional Method and
Molecular Method.
By
Service Type: Centralized Service and Point-of-care
Testing (POCT).
By
End User: Hospitals and Clinics, Home
Healthcare, Clinical Laboratories, and Others.
By Geography: North
America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain,
Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea,
Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil,
Argentina, and Rest of South America) and Rest of World (Middle East and
Africa).
Key Takeaways
- Geographically, North America Neglected Tropical Diseases Diagnosis Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing demand for rapid diagnostic tests for the treatment of lymphatic filariasis.
- The rise in the adoption of point-of-care testing for dengue virus detection in developed nations is driving the Dengue segment. However, the high cost for diagnosis of neglected tropical diseases and their research and development activities is one of the major factors that is said to reduce the growth of the Neglected Tropical Diseases Diagnosis Market.
- Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Neglected Tropical Diseases Diagnosis Market report.
Neglected Tropical Diseases Diagnosis Market: Market Share (%) By End User, 2020
Neglected Tropical Diseases Diagnosis Market Segment Analysis-By Disease
The Neglected Tropical Diseases Diagnosis Market based on the Disease can be further segmented into Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others. The Dengue segment held the largest share in 2020 owing to the factors such as growing continuous efforts by the healthcare companies to develop and commercialize less complicated disease diagnostic platforms and rise in the availability of diagnostic kits for dengue virus detection.
The rise in the adoption of point-of-care testing for dengue virus detection in developed nations is driving the growth of the Neglected Tropical Diseases Diagnosis Market. The Lymphatic Filariasis segment is estimated to be the fastest growing segment with a CAGR of 5.8% over the period 2021-2026. This growth is owing to the factors such as the growing demand for rapid diagnostic tests to detect the antigen of the major species of filarial worm in human blood and the rise in the prevalence of lymphatic system disorders across the world.
Neglected Tropical Diseases Diagnosis Market Segment Analysis-By End User
The Neglected Tropical Diseases Diagnosis Market based on the End User can be further segmented into Hospitals and Clinics, Home Healthcare, Clinical Laboratories, and Others. The Clinical Laboratories segment held the largest share in 2020 owing to the factors such as rise in the presence of number of laboratories across the world and the growing availability of advanced equipment in clinical laboratories.
The rise in the research and development activities on lymphatic filariasis owing to the rise in the prevalence of lymphatic system disorders is driving the growth of the Neglected Tropical Diseases Diagnosis Market. The Home Healthcare segment is estimated to be the fastest growing segment with a CAGR of 5.3% over the period 2021-2026. This growth is owing to the factors such as the growing adoption of point-of-care testing services at home healthcare and the rise in awareness about the benefits of diagnosis at home healthcare among patients in developing nations.
Neglected Tropical Diseases Diagnosis Market Segment Analysis-By Geography
North America held the largest share with 29% of the overall market in
2020. The growth in this segment is owing to the factors such as rise in the adoption of point-of-care testing services at home
healthcare and the growing implementation of robust diagnostic methods. The increasing demand for rapid
diagnostic tests for the treatment of lymphatic filariasis is driving the growth of the Neglected
Tropical Diseases Diagnosis Market. Asia-Pacific segment is estimated to be the
fastest growing segment over the period 2021-2026. The growth in this segment
is owing to the factors such as rise in the availability of diagnostic
kits for dengue virus detection and increasing continuous efforts by the
healthcare companies to develop less complicated disease diagnostic platforms.
Neglected Tropical Diseases Diagnosis Market Drivers
Increase in the Adoption of Point-of-Care Testing Services
Point-of-care (POC) testing services are increasingly being used as diagnostic tools for the prompt diagnosis for neglected tropical diseases at POC settings owing to its cost-effectiveness and user-friendliness. Point-of-care (POC) testing services have the ability to provide rapid actionable information for patient care during an encounter with the health care system, which is further propelling the growth of the Neglected Tropical Diseases Diagnosis Market.
Rise in the Prevalence of Lymphatic Filariasis
The
rise in the number of lymphatic system disorders across the world and the growing
prevalence of elephantiasis have increased the prevalence of lymphatic filariasis.
The World Health Organization (WHO) is increasing its awareness campaigns for
the treatment of lymphatic filariasis. The rapid diagnostic tests are also
increasingly being adopted for the treatment of lymphatic filariasis across the
world, which is one of the major factors driving the growth of the Neglected Tropical Diseases
Diagnosis Market.
Neglected Tropical Diseases Diagnosis Market Challenges
High Cost of Neglected Tropical Diseases Diagnosis
The
government of several nations and organizations are increasing their
initiatives to enhance awareness among people about various tropical diseases and
to increase the consumer’s inclination towards rapid diagnostic tests for the
treatment of these diseases. However, the high cost for diagnosis of neglected
tropical diseases and their research and development activities is one of the
major factors that is estimated to reduce the growth of the Neglected Tropical Diseases Diagnosis
Market.
Neglected Tropical Diseases Diagnosis Market Competitive Landscape:
Product launches,
mergers and acquisitions, joint ventures, and geographical expansions are key
strategies adopted by players in the Neglected Tropical Diseases
Diagnosis Market. Key
companies of this market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific
Inc, InBios International Inc, Omega Diagnostics Group, Oscar Medicare Pvt Ltd,
EUROIMMUN, Novartis AG, Grifols, ZeptoMetrix, and DiaSys Diagnostic Systems
GmbH among others.
Acquisitions/Product Launches:
In March 2021, EUROIMMUN has launched the
EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope for
state-of-the-art diagnostics for the treatment of Echinococcosis
and to enhance the quality and efficiency of indirect immunofluorescence
testing.
In January 2021, Novartis AG has entered into a
partnership with World Health Organization (WHO) to donate multidrug therapy
(MDT) medicines to treat leprosy and to focus on deploying additional tools for
the treatment of leprosy.
In April 2020, Grifols has launched a new 3-mL vial
for high-potency HyperRAB, a potency formulation of rabies immunoglobulin that provides
storage efficiencies for hospital pharmacies and decreases the number of
smaller vials for the treatment for rabies postexposure prophylaxis.
Relevant Reports:
Report
Code: HCR 40147
Report
Code: HCR 92228
For more Lifesciences and Healthcare Market reports, please click here
LIST OF TABLES
1.Global Competitive Landscape Market 2023-2030 ($M)1.1 List Of Companies Market 2023-2030 ($M) - Global Industry Research
1.2 Market Participation Categorization Market 2023-2030 ($M) - Global Industry Research
2.Global Competitive Landscape Market 2023-2030 (Volume/Units)
2.1 List Of Companies Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Market Participation Categorization Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Competitive Landscape Market 2023-2030 ($M)
3.1 List Of Companies Market 2023-2030 ($M) - Regional Industry Research
3.2 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
4.South America Competitive Landscape Market 2023-2030 ($M)
4.1 List Of Companies Market 2023-2030 ($M) - Regional Industry Research
4.2 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
5.Europe Competitive Landscape Market 2023-2030 ($M)
5.1 List Of Companies Market 2023-2030 ($M) - Regional Industry Research
5.2 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
6.APAC Competitive Landscape Market 2023-2030 ($M)
6.1 List Of Companies Market 2023-2030 ($M) - Regional Industry Research
6.2 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
7.MENA Competitive Landscape Market 2023-2030 ($M)
7.1 List Of Companies Market 2023-2030 ($M) - Regional Industry Research
7.2 Market Participation Categorization Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)2.Canada Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
3.Mexico Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
4.Brazil Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
5.Argentina Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
6.Peru Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
7.Colombia Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
8.Chile Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
9.Rest of South America Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
10.UK Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
11.Germany Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
12.France Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
13.Italy Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
14.Spain Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
15.Rest of Europe Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
16.China Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
17.India Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
18.Japan Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
19.South Korea Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
20.South Africa Neglected Tropical Diseases Diagnosis Market Revenue, 2023-2030 ($M)
21.North America Neglected Tropical Diseases Diagnosis By Application
22.South America Neglected Tropical Diseases Diagnosis By Application
23.Europe Neglected Tropical Diseases Diagnosis By Application
24.APAC Neglected Tropical Diseases Diagnosis By Application
25.MENA Neglected Tropical Diseases Diagnosis By Application